Semprus BioSciences Awarded $1 Million U.S. Army Grant to Develop "Anti-Biofilm Trauma Devices" for American Soldiers in Battle
Semprus BioSciences today announced it has received a $1 million grant from the U.S. Army Telemedicine & Advanced Technology Research Center (TATRC) to develop the world's first orthopedic devices designed to reduce biofilm formation, the foundation for most bacterial complications associated with medical device implants. - October 21, 2011
Semprus BioSciences Appoints Alonzo D. Cook, Ph.D. Group Leader, Research
Semprus BioSciences today announced the appointment of Alonzo (Lon) D. Cook, Ph.D., to the newly-created post of Group Leader, Research, effective immediately. - September 22, 2011
2006 MIT $100K Business Plan Winner - Semprus BioSciences - Hosts Final Judging Round for 2011 Life Sciences Competitors
Semprus BioSciences today announced it will host the final round of judging for the Life Sciences Track of the 2011 MIT $100K Entrepreneurship Competition on Monday, May 2. The five finalist teams will pitch their business plans to a judging panel that includes Semprus Chief Technology Officer... - April 30, 2011
Semprus BioSciences to Present at SIR's 36th Annual Scientific Meeting
Semprus BioSciences today announced its Chief Technology Officer Christopher Loose, Ph.D., will present the company's groundbreaking data results on its non-fouling Semprus Platform at SIR's 36th Annual Scientific Meeting. - March 16, 2011
Semprus BioSciences CEO Elected to AdvaMed Board of Directors
Semprus BioSciences today announced the election of its Chief Executive Officer David L. Lucchino to the Advanced Medical Technology Association (AdvaMed) Board of Directors. AdvaMed, based in Washington, D.C., is the world’s largest trade association, representing approximately 400 of the... - March 10, 2011
MIT/Harvard Broad Institute Scientist Joins Semprus BioSciences
Semprus BioSciences today announced the appointment of Roger Smith, Ph.D., as the company's new microbiology team leader. - February 11, 2011
Semprus BioSciences Names Ulla Wallin Director of Clinical Affairs
Semprus BioSciences today announced the appointment of Ulla B. Wallin, BSN, Sc.M., as the company’s first Director of Clinical Affairs. - January 07, 2011